PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSelenomethionine se-75
Selenomethionine se-75
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
45 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Autoimmune thyroiditisD013967EFO_0006812E06.31135
Hashimoto diseaseD050031EFO_0003779E06.31135
ThyroiditisD013966E06134
Liver diseasesD008107EFO_0001421K70-K77112
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.8111
Fatty liverD005234EFO_000393411
AsthmaD001249EFO_0000270J4511
RhinitisD012220EFO_0008521J3111
Allergic conjunctivitisD003233EFO_0007141H10.4411
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471C6123218
Colorectal neoplasmsD0151791124
NeoplasmsD009369C801113
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9123
Obstructive lung diseasesD008173123
Precancerous conditionsD01123022
Non-small-cell lung carcinomaD002289112
Lung neoplasmsD008175C34.90112
InfectionsD007239EFO_000054411
Hiv infectionsD015658EFO_0000764B2011
Show 9 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Renal cell carcinomaD002292EFO_0000376212
Rectal neoplasmsD01200411
Adenocarcinoma of lungD00007719211
Bronchiolo-alveolar adenocarcinomaD00228211
Squamous cell carcinoma of head and neckD00007719511
Squamous cell carcinomaD00229411
XerostomiaD014987K11.711
MucositisD052016EFO_100189811
Radiation injuriesD011832T6611
Radiation effectsD01183011
Show 2 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Kidney neoplasmsD007680EFO_0003865C6411
DiseaseD004194EFO_0000408R6911
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FibrosisD00535522
Impulsive behaviorD00717511
InfertilityD007246EFO_000054511
PregnancyD011247EFO_0002950Z33.111
InflammationD007249MP_000184511
Graves diseaseD006111EFO_0004237E05.011
HyperthyroidismD006980E05.911
Facioscapulohumeral muscular dystrophyD020391EFO_0000491G71.0211
Motor activityD009043EFO_000394011
Nutritional requirementsD00975111
Show 5 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name
INN
Description
Classification
Unknown
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL ID
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,065 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use